
Sanofi SNY
$ 47.37
0.13%
Annual report 2024
added 02-14-2026
Sanofi DIO Ratio 2011-2026 | SNY
Annual DIO Ratio Sanofi
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 235 | 218 | 217 | 211 | 209 | 203 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 235 | 203 | 216 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
4.89 | $ 0.82 | 1.9 % | $ 4.47 M | ||
|
Aquestive Therapeutics
AQST
|
131 | $ 4.18 | 2.32 % | $ 363 M | ||
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Axsome Therapeutics
AXSM
|
168 | $ 165.2 | -2.79 % | $ 8.22 B | ||
|
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
351 | $ 190.58 | -2.33 % | $ 27.9 B | ||
|
BioMarin Pharmaceutical
BMRN
|
736 | $ 61.56 | -1.7 % | $ 11.7 B | ||
|
Baudax Bio
BXRX
|
596 | - | 0.59 % | $ 63 K | ||
|
Amneal Pharmaceuticals
AMRX
|
123 | $ 14.68 | 0.1 % | $ 4.54 B | ||
|
CASI Pharmaceuticals
CASI
|
47.4 | $ 0.35 | -55.89 % | $ 47.6 M |